Navaratna M A, Sahl H G, Tagg J R
Department of Microbiology, University of Otago, Dunedin, New Zealand.
Appl Environ Microbiol. 1998 Dec;64(12):4803-8. doi: 10.1128/AEM.64.12.4803-4808.1998.
Staphylococcus aureus C55 was shown to produce bacteriocin activity comprising three distinct peptide components, termed staphylococcins C55alpha, C55beta, and C55gamma. The three peptides were purified to homogeneity by a simple four-step purification procedure that consisted of ammonium sulfate precipitation followed by XAD-2 and reversed-phase (C8 and C18) chromatography. The yield following C8 chromatography was about 86%, with a more-than-300-fold increase in specific activity. When combined in approximately equimolar amounts, staphylococcins C55alpha and C55beta acted synergistically to kill S. aureus or Micrococcus luteus but not S. epidermidis strains. The N-terminal amino acid sequences of all three peptides were obtained and staphylococcins C55alpha and C55beta were shown to be lanthionine-containing (lantibiotic) molecules with molecular weights of 3,339 and 2,993, respectively. The C55gamma peptide did not appear to be a lantibiotic, nor did it augment the inhibitory activities of staphylococcin C55alpha and/or C55beta. Plasmids of 2. 5 and 32.0 kb are present in strain C55, and following growth of this strain at elevated temperature (42 degreesC), a large proportion of the progeny failed to produce strong bacteriocin activity and also lost the 32.0-kb plasmid. Protoplast transformation of these bacteria with purified 32-kb plasmid DNA regenerates the ability to produce the strong bacteriocin activity.
金黄色葡萄球菌C55被证明能产生具有三种不同肽成分的细菌素活性,这三种肽分别被称为葡萄球菌素C55α、C55β和C55γ。通过一个简单的四步纯化程序将这三种肽纯化至同质,该程序包括硫酸铵沉淀,随后进行XAD - 2和反相(C8和C18)色谱。C8色谱后的产率约为86%,比活性增加了300多倍。当以大约等摩尔量组合时,葡萄球菌素C55α和C55β协同作用以杀死金黄色葡萄球菌或藤黄微球菌,但对表皮葡萄球菌菌株无效。获得了所有三种肽的N端氨基酸序列,并且显示葡萄球菌素C55α和C55β是分别含有分子质量为3339和2993的羊毛硫氨酸的(羊毛硫抗生素)分子。C55γ肽似乎不是羊毛硫抗生素,也不增强葡萄球菌素C55α和/或C55β的抑制活性。菌株C55中存在2.5 kb和32.0 kb的质粒,在该菌株于高温(42℃)下生长后,大部分子代未能产生强细菌素活性,并且还丢失了32.0 kb的质粒。用纯化的32 kb质粒DNA对这些细菌进行原生质体转化可恢复产生强细菌素活性的能力。